What is a stock summary page? Click here for an overview.
Business Description
Biora Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US74319F3055
Share Class Description:
BIOR: Ordinary SharesDescription
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | -7.35 | |||||
| Debt-to-Equity | -0.37 | |||||
| Debt-to-EBITDA | -1.42 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -109.22 | |||||
| Beneish M-Score | 34.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -87.3 | |||||
| 3-Year EBITDA Growth Rate | 57.8 | |||||
| 3-Year EPS without NRI Growth Rate | 54.5 | |||||
| 3-Year FCF Growth Rate | 72.9 | |||||
| 3-Year Book Growth Rate | 57.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 55.72 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 680.76 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.82 | |||||
| 9-Day RSI | 12.15 | |||||
| 14-Day RSI | 17.05 | |||||
| 6-1 Month Momentum % | -95.8 | |||||
| 12-1 Month Momentum % | -97.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.05 | |||||
| Quick Ratio | 0.05 | |||||
| Cash Ratio | 0.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -132 | |||||
| Shareholder Yield % | 6172.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -6824.33 | |||||
| Net Margin % | -3535.76 | |||||
| FCF Margin % | -5179.71 | |||||
| ROA % | -129.6 | |||||
| ROIC % | -100.29 | |||||
| 3-Year ROIIC % | 67.76 | |||||
| ROC (Joel Greenblatt) % | -1087.18 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.93 | |||||
| EV-to-EBIT | -1.32 | |||||
| EV-to-Forward-EBIT | -0.55 | |||||
| EV-to-EBITDA | -1.34 | |||||
| EV-to-Forward-EBITDA | -0.55 | |||||
| EV-to-Revenue | 41.98 | |||||
| EV-to-Forward-Revenue | 7.49 | |||||
| EV-to-FCF | -0.81 | |||||
| Price-to-GF-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -75.76 | |||||
| FCF Yield % | -4643.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIOR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biora Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.892 | ||
| EPS (TTM) ($) | -13.04 | ||
| Beta | 1.32 | ||
| 3-Year Sharpe Ratio | -1.62 | ||
| 3-Year Sortino Ratio | -1.74 | ||
| Volatility % | 98.77 | ||
| 14-Day RSI | 17.05 | ||
| 14-Day ATR ($) | 0.002061 | ||
| 20-Day SMA ($) | 0.22 | ||
| 12-1 Month Momentum % | -97.05 | ||
| 52-Week Range ($) | 0.15 - 7.9 | ||
| Shares Outstanding (Mil) | 4.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biora Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biora Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biora Therapeutics Inc Frequently Asked Questions
What is Biora Therapeutics Inc(BIOR)'s stock price today?
The current price of BIOR is $0.22. The 52 week high of BIOR is $7.90 and 52 week low is $0.15.
When is next earnings date of Biora Therapeutics Inc(BIOR)?
The next earnings date of Biora Therapeutics Inc(BIOR) is 2025-04-09 Est..
Does Biora Therapeutics Inc(BIOR) pay dividends? If so, how much?
Biora Therapeutics Inc(BIOR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers